ALMDP — Medesis Pharma SA Share Price
0.000.00%
Last trade - 00:00- €5.89m
- €8.29m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 0.31 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -417.1% | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 0.01 | 0.2 | 0.2 | 0.07 | n/a | n/a | 20 | -100% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Medesis Pharma SA is a France-based clinical development stage biopharmaceutical Company. The Company is engaged through its drug delivery technology Aonys in the development of orally administered molecule drug candidates to expand their therapeutic usefulness to address unmet medical needs. Its technology is also being used for collaborative research programs focused on oncology (customized cancer treatment) and radiotherapy (protection of healthy tissue). The Company’s two drug candidates for treating people contaminated following a civil or military nuclear accident are Plutonium decorporation and Cesium decorporation.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- April 3rd, 2003
- Public Since
- February 12th, 2021
- No. of Employees
- 10
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Euronext - Paris
- Shares in Issue
- 4,429,081
- Address
- Montpellier, BAILLARGUES, 34670
- Web
- https://www.medesispharma.com/
- Phone
- +33 467030396
- Auditors
- JPA
Upcoming Events for ALMDP
Medesis Pharma SA Annual Shareholders Meeting
Similar to ALMDP
Abionyx Pharma SA
Euronext - Paris
Abivax SA
Euronext - Paris
Acticor Biotech SA
Euronext - Paris
Adocia SA
Euronext - Paris
Biophytis SA
Euronext - Paris
FAQ
What is the Medesis Pharma SA share price?
As of Today at 19:14 UTC, shares in Medesis Pharma SA are trading at €1.33. This share price information is delayed by 15 minutes.
How has the Medesis Pharma SA share price performed this year?
Shares in Medesis Pharma SA last closed at €1.33 and the price had moved by -46.59% over the past 365 days. In terms of relative price strength the Medesis Pharma SA share price has underperformed the FTSE Global All Cap Index by -50.73% over the past year.
What are the analyst and broker recommendations for Medesis Pharma SA?
The overall consensus recommendation for Medesis Pharma SA is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Medesis Pharma SA dividend yield?
Medesis Pharma SA does not currently pay a dividend.
Does Medesis Pharma SA pay a dividend?
Medesis Pharma SA does not currently pay a dividend.
When does Medesis Pharma SA next pay dividends?
Medesis Pharma SA does not currently pay a dividend.
How do I buy Medesis Pharma SA shares?
To buy shares in Medesis Pharma SA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Medesis Pharma SA?
As of the previous close price of €1.33, shares in Medesis Pharma SA had a market capitalisation of €5.89m.
Where are Medesis Pharma SA shares listed?
Here are the trading details for Medesis Pharma SA:
- Country of listing: France
- Exchange: PAR
- Ticker Symbol: ALMDP
What kind of share is Medesis Pharma SA?
Based on an overall assessment of its quality, value and momentum Medesis Pharma SA is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Medesis Pharma SA share price forecast for 2024?
The analyst consensus target price for shares in Medesis Pharma SA is €3.30. That is 148.12% above the last closing price of €1.33.
Analysts covering Medesis Pharma SA currently have a consensus Earnings Per Share (EPS) forecast of -€0.67 for the next financial year.
What is the trend in the Medesis Pharma SA share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medesis Pharma SA. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +35.01%.
As of the last closing price of €1.33, shares in Medesis Pharma SA were trading +20.37% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Medesis Pharma SA PE Ratio?
The Medesis Pharma SA PE ratio based on its reported earnings over the past 12 months is 0.31. The shares last closed at €1.33.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Medesis Pharma SA?
We do not have data on Medesis Pharma SA's directors